Latest News about LGVN
Recent news which mentions LGVN
Why Accolade Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
October 05, 2023
From Benzinga
Longeveron stock jumps on Alzheimer’s trial results
October 05, 2023
From MarketWatch
12 Health Care Stocks Moving In Friday's Pre-Market Session
September 15, 2023
From Benzinga
Roth MKM Analyst Projects An Impressive Price Target Of $15 Over The Next 12 Months For BioRestorative Therapies (NASDAQ: BRTX), Says "Low Valuation Undeserved"
September 14, 2023
From Benzinga
Longeveron (NASDAQ: LGVN) Reports 100% 5-Year Survival In Trial For Rare Pediatric Disease HLHS (Compared To 80% Survival In Historical Trials) To Market
September 11, 2023
From Benzinga
Upcoming Phase 2 Data Expected For Longeveron's (NASDAQ: LGVN) Drug For the $4+ Billion Alzheimer's Sector – What To Look For
September 06, 2023
From Benzinga
Why Lands' End Are Trading Lower By 22%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
August 31, 2023
From Benzinga
US Stocks Rise; Initial Jobless Claims Edge Lower
August 31, 2023
From Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
August 31, 2023
From Benzinga
As America Grapples With A Deadly Opioid Epidemic, BioRestorative Therapies Is Looking To Treat Chronic Pain Without The Need For Class-A Drugs
August 29, 2023
From Benzinga
Earnings Scheduled For August 11, 2023
August 11, 2023
From Benzinga
Longeveron – This Biotech Company Is Using The Body's Own Cells To Fight Age-Related Diseases
August 07, 2023
Tickers
LGVN
From Benzinga
From Benzinga
Longeveron – Regenerative Medicine Developer Announces 100% Long Term Survival Rate For Children With HLHS
July 11, 2023
Tickers
LGVN
From Benzinga
From Benzinga
Tickers
LGVN
From InvestorPlace
Earnings Scheduled For May 12, 2023
May 12, 2023
From Benzinga
From Benzinga
Why PRA Group Shares Are Trading Lower By 44%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
May 09, 2023
From Benzinga
Why Is Longeveron (LGVN) Stock Up 30% Today?
May 09, 2023
From InvestorPlace
Longeveron Doses First Patient In Phase 2 Clinical Trial Of Lomecel-B™ In Japan For Aging-Related Frailty
April 20, 2023
Tickers
LGVN
From Benzinga
Stocks That Hit 52-Week Lows On Tuesday
March 21, 2023
From Benzinga
Earnings Scheduled For March 10, 2023
March 10, 2023
From Benzinga
From InvestorPlace
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.